Showing 18,381 - 18,400 results of 18,478 for search '(( 10 ((mg decrease) OR (nn decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 0.64s Refine Results
  1. 18381
  2. 18382
  3. 18383
  4. 18384

    DataSheet_1_Zerumbone Modulates α2A-Adrenergic, TRPV1, and NMDA NR2B Receptors Plasticity in CCI-Induced Neuropathic Pain In Vivo and LPS-Induced SH-SY5Y Neuroblastoma In Vitro Mod... by Jasmine Siew Min Chia (8524626)

    Published 2020
    “…Involvement of specific adrenoceptors were investigated using antagonists— prazosin (α<sub>1</sub>-adrenoceptor antagonist), idazoxan (α<sub>2</sub>-adrenoceptor antagonist), metoprolol (β<sub>1</sub>-adrenoceptor antagonist), ICI 118,551 (β<sub>2</sub>-adrenoceptor antagonist), and SR 59230 A (β<sub>3</sub>-adrenoceptor antagonist), co-administered with zerumbone (10 mg/kg). Involvement of excitatory receptors; TRPV and NMDA were conducted using antagonists capsazepine (TRPV1 antagonist) and memantine (NMDA antagonist). …”
  5. 18385

    <i>pals-17</i> mutant phenotypes are fully <i>pals-16</i>-dependent. by Vladimir Lažetić (5047592)

    Published 2023
    “…<p>(A, B) <i>pals-16</i> RNAi decreases <i>pals-5</i>p::GFP expression in <i>pals-17 pals-20</i> mutants. …”
  6. 18386

    DataSheet2_Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer... by Mohamed S. Nafie (9754305)

    Published 2024
    “…<p>Cancer represents a global challenge, and the pursuit of developing new cancer treatments that are potent, safe, less prone to drug resistance, and associated with fewer side effects poses a significant challenge in cancer research and drug discovery. …”
  7. 18387

    DataSheet1_Exploring pyrrolidinyl-spirooxindole natural products as promising platforms for the synthesis of novel spirooxindoles as EGFR/CDK2 inhibitors for halting breast cancer... by Mohamed S. Nafie (9754305)

    Published 2024
    “…<p>Cancer represents a global challenge, and the pursuit of developing new cancer treatments that are potent, safe, less prone to drug resistance, and associated with fewer side effects poses a significant challenge in cancer research and drug discovery. …”
  8. 18388

    Fig 4 - by Laure Bridoux (481118)

    Published 2020
    “…The highest HOX dose corresponds to 100%; HOXA2 (red) is translated at progressively decreasing levels, either alone, or co-translated with progressively increasing levels of HOXA3 (green) (e.g. 75% HOXA2; 75% HOXA2 + 25% HOXA3; 50% HOXA2; 50%HOXA2 + 50% HOXA3; 50% HOXA3 as indicated below the gel). …”
  9. 18389

    Table_1_Feasibility and Effect of Physiological-Based CPAP in Preterm Infants at Birth.pdf by Tessa Martherus (8116559)

    Published 2021
    “…PB-CPAP consisted of 15 cmH<sub>2</sub>O CPAP that was decreased when infants were stabilized (heart rate ≥100 bpm, SpO<sub>2</sub> ≥85%, FiO<sub>2</sub> ≤ 0.4, spontaneous breathing) to 8 cmH<sub>2</sub>O with steps of ~2/3 cmH<sub>2</sub>O/min. …”
  10. 18390

    Table_1_Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.docx by Fei-Fei Xu (538090)

    Published 2022
    “…After a median follow-up of 69 months, the 5-year rate of DFS, BCSS, and LRR in the overall cohort was 90.2%, 97.4%, and 3.6%, respectively. …”
  11. 18391

    Table_1_Ebola vaccine uptake and attitudes among healthcare workers in North Kivu, Democratic Republic of the Congo, 2021.docx by Reena H. Doshi (5770502)

    Published 2023
    “…</p>Methods<p>In March 2021, we conducted a cross-sectional survey among 438 HCWs from 100 randomly selected health facilities in three health zones (Butembo, Beni, Mabalako) affected by the 10th EVD outbreak in North Kivu, DRC. …”
  12. 18392

    Defective eviction of nucleosomes surrounding 5’ Gcn4 motifs in SWI/SNF and RSC mutants. by Yashpal Rawal (606804)

    Published 2022
    “…<b>(C-E)</b> Notched box plots for the 3 sets of 5’ sites defined in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010277#pgen.1010277.g002" target="_blank">Fig 2A and 2B</a> and indicated again in (B), depicting (C) H3 occupancies per base pair in the ±100 bp windows surrounding the Gcn4 motifs, (D) log<sub>2</sub> Gcn4 occupancies taken from <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010277#pgen.1010277.g002" target="_blank">Fig 2C</a>, and (E) log<sub>2</sub> Rpb3 occupancies averaged over the CDS of genes with 5’ sites. …”
  13. 18393

    Table_1_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx by Ron Milo (22493)

    Published 2022
    “…Serological responses were measured by quantifying IgG levels against the spike-receptor-binding-domain of SARS-CoV-2, and cellular responses (in a subgroup analysis) by quantifying IFNγ secretion in blood incubated with COVID-19 spike-antigen.…”
  14. 18394

    Table_2_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx by Ron Milo (22493)

    Published 2022
    “…Serological responses were measured by quantifying IgG levels against the spike-receptor-binding-domain of SARS-CoV-2, and cellular responses (in a subgroup analysis) by quantifying IFNγ secretion in blood incubated with COVID-19 spike-antigen.…”
  15. 18395

    Characterizing the connectivity of in vitro neuronal networks. by Christian Donner (3663007)

    Published 2024
    “…<p><b>A</b> Firing rate cumulative density function (CDF) of 600 spike-sorted units from HD-MEA recordings obtained from primary cortical cultures (top panel; n = 6 cultures; 100 units per network; recording duration: 1 h; culture age: DIV 14); and CDF of inter-spike interval coefficients of variation (ISI CV) for the same cultures (lower panel). …”
  16. 18396

    Table_3_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.docx by Ron Milo (22493)

    Published 2022
    “…Serological responses were measured by quantifying IgG levels against the spike-receptor-binding-domain of SARS-CoV-2, and cellular responses (in a subgroup analysis) by quantifying IFNγ secretion in blood incubated with COVID-19 spike-antigen.…”
  17. 18397

    Comparison of CBVs in different brain regions of WT and Katnal2-KO mice. by Ryeonghwa Kang (6793046)

    Published 2024
    “…<p>(A) Comparisons of cerebral blood volumes (CBVs) in WT and Katnal2-KO brains, as shown by the extents of decreases in fMRI signals induced by hypoxic nitrogen stimulus in different brain regions (left, relative CBVs) and the KO values normalized to WT values (right, %WT). …”
  18. 18398

    Table 1_Vitamin D3 promotes white fat beige through IL-27/P38MAPK/PGC-1α pathway.docx by Yanqiu Zhou (2172931)

    Published 2025
    “…After VD<sub>3</sub> intervention, TC, TG, and the number of LDs were significantly reduced in both HFD rats and 3T3-L1 cells, and serum IL-6 and MCP-1 in HFD rats were decreased. Meanwhile, there was a significant increase in mRNA and protein expression for VDR, IL-27R, P38MAPK, and PGC-1α. …”
  19. 18399

    Image_1_Humoral and Cellular Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients with Multiple Sclerosis: An Israeli Multi-Center Experience Following 3 Vaccine Doses.tif by Ron Milo (22493)

    Published 2022
    “…Serological responses were measured by quantifying IgG levels against the spike-receptor-binding-domain of SARS-CoV-2, and cellular responses (in a subgroup analysis) by quantifying IFNγ secretion in blood incubated with COVID-19 spike-antigen.…”
  20. 18400

    MDT-15 limits the growth and longevity at low temperatures. by Dongyeop Lee (108880)

    Published 2019
    “…We were able to maintain <i>mdt-15(-)</i> worms at low temperatures because the embryonic lethality was not 100%. See <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000415#pbio.3000415.s007" target="_blank">S1</a> and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000415#pbio.3000415.s008" target="_blank">S2</a> Tables for statistical analysis and additional repeats of the life-span assays, as well as <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000415#pbio.3000415.s012" target="_blank">S6 Table</a> for the Cox proportional hazard regression analysis for this and other figures and <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000415#pbio.3000415.s013" target="_blank">S7 Table</a> for the standard deviations of box plot data. …”